We further assayed the levels of SRSF2, LOXL4 and Ki67 (an indicator for cell proliferation) in the tumor sessions of the Pa-treated versus PBS-treated mice (Figure 6E and Additional file1: Figure S1), by the immuno-histological analysis. The gene discussed is LOXL4; the disease is neoplasm.